ABC294640

YELIVA®

Overview

ABC294640 is a new drug being investigated as a treatment for myeloma. It is administered orally and has anti-cancer and anti-inflammatory activities.

SparkCures ID 254
Brand Name Yeliva®
Generic Name ABC294640

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.